ATE219668T1 - Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie - Google Patents

Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie

Info

Publication number
ATE219668T1
ATE219668T1 AT97909364T AT97909364T ATE219668T1 AT E219668 T1 ATE219668 T1 AT E219668T1 AT 97909364 T AT97909364 T AT 97909364T AT 97909364 T AT97909364 T AT 97909364T AT E219668 T1 ATE219668 T1 AT E219668T1
Authority
AT
Austria
Prior art keywords
pct
tissues
mercaptoethanesulfonate
sodium
surgery
Prior art date
Application number
AT97909364T
Other languages
English (en)
Inventor
Carlo Zini
Salvatore Bacciu
Angelo Gandolfi
Fabio Piazza
Enrico Pasanisi
Original Assignee
A R D O Associazione Ricerca E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A R D O Associazione Ricerca E filed Critical A R D O Associazione Ricerca E
Application granted granted Critical
Publication of ATE219668T1 publication Critical patent/ATE219668T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
AT97909364T 1996-10-11 1997-10-07 Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie ATE219668T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002117A IT1284973B1 (it) 1996-10-11 1996-10-11 Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
PCT/EP1997/005485 WO1998016213A1 (en) 1996-10-11 1997-10-07 Use of sodium 2-mercaptoethanesulfonate in surgery

Publications (1)

Publication Number Publication Date
ATE219668T1 true ATE219668T1 (de) 2002-07-15

Family

ID=11375023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97909364T ATE219668T1 (de) 1996-10-11 1997-10-07 Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie

Country Status (9)

Country Link
US (1) US6143797A (de)
EP (1) EP0930878B1 (de)
JP (1) JP4208967B2 (de)
AT (1) ATE219668T1 (de)
AU (1) AU4707797A (de)
DE (1) DE69713611T2 (de)
ES (1) ES2178760T3 (de)
IT (1) IT1284973B1 (de)
WO (1) WO1998016213A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030175A1 (it) * 2003-02-04 2004-08-05 Giorgio Conti Uso del 2-mercaptoetansolfonato di sodio come agente antivirale
CA2587081A1 (en) * 2004-12-10 2006-06-22 Alcon, Inc. Compositions for treatment of ear infections
WO2015071910A1 (en) 2013-11-17 2015-05-21 Rdd Pharma Ltd. Methods for treating radiation induced gastrointestinal tract injury
WO2021013713A1 (en) 2019-07-19 2021-01-28 Auxin Surgery Sa Mesna composition, kit comprising mesna and method for visualization of a mesna composition applied to tissues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244920A (en) * 1985-04-15 1993-09-14 Schering Spa Pharmaceutical compositions having therapeutical activity based on mercaptoethansulphonic arginine salt
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung
DE4233842A1 (de) * 1992-10-08 1994-04-14 Asta Medica Ag Mesna Injektionslösungen
US5661188A (en) * 1995-06-07 1997-08-26 Medical Research Foundation and Infrastructure Development for Health Services--Nahariya Hospital Branch Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna)

Also Published As

Publication number Publication date
DE69713611T2 (de) 2003-01-30
EP0930878A1 (de) 1999-07-28
AU4707797A (en) 1998-05-11
IT1284973B1 (it) 1998-05-28
DE69713611D1 (de) 2002-08-01
WO1998016213A1 (en) 1998-04-23
US6143797A (en) 2000-11-07
JP4208967B2 (ja) 2009-01-14
JP2001508033A (ja) 2001-06-19
ES2178760T3 (es) 2003-01-01
EP0930878B1 (de) 2002-06-26
ITMI962117A1 (it) 1998-04-11

Similar Documents

Publication Publication Date Title
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ATE317262T1 (de) Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion
DK1140969T3 (da) Bindevævsvækstfaktorfragmenter og fremgangsmåder og anvendelser deraf
DE59510968D1 (de) Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
BR9911017A (pt) Derivados de indol e seu emprego para o tratamento de doenças malignas e outras, que se baseiam na proliferação de células patológicas
ID21927A (id) Asam aminoalkanafosfonat tersubstitusi
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
DE69839696D1 (de) Anellierte dihydropyrane
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
DE69838509D1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
ATE219668T1 (de) Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie
DE69939723D1 (de) Verwendung von Intereferon Gamma zur Behandlung von Herzhypertrophie
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
TR200200278T2 (tr) Kalsilitik bileşimler
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
PT1152757E (pt) Inibidores de mmp no amolecimento do tecido conjuntivo
DE69724944D1 (de) Peptidverbindungen mit mmp- und tnf-hemmender wirkung
DE59910697D1 (de) Verwendung von D-Galaktose zur Verhinderung von Nekrosen
DE69626010D1 (de) Verwendung von tropolon derivate zur hemmung des inositmono phosphatase
ATE313329T1 (de) Disaccharidderivate zur behandlung von hyperglykämien
NO984965L (no) Komponent B som cicatrisant

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties